China Resources Medical Holdings Company Limited (1515) estimates that profit attributable to owners for the year ended December 31, 2025, will range from RMB467.00 million to RMB516.00 million, reflecting a drop of around 17.5% to 8.9% compared with RMB566.00 million for 2024. Excluding the Yan Hua Compensation and corresponding tax, the profit decrease is estimated to be around 43.5% to 37.6% compared to 2024, with the decline narrowing by 13.9 to 19.8 percentage points from the first half of 2025.

The decrease is mainly attributed to lower operating profits, stemming from a reduction in average medical insurance fee per visit and a scaling back of the Company’s invest-operate-transfer business. In the second half of 2025, total revenue and patient visits rose compared with the first half. Bank borrowings fell by about RMB780.00 million from the end of 2024, reducing interest-bearing debt and ensuring adequate cash flow. Meanwhile, healthcare management revenue showed growth year-on-year, with new initiatives including a “Runxin healthcare hut” at China Resources Tower in Shenzhen and pilot projects such as “internet+in-home nursing.”

All data and content are based on the Company’s preliminary assessment of its unaudited consolidated management accounts, which are yet to be reviewed by the audit committee or audited by external auditors. Interested parties are advised to refer to the Company’s forthcoming annual results announcement, expected before the end of March 2026, for final details.